Repligen (RGEN) Other Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Other Operating Expenses data on file, last reported at -$13.8 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$13.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $246.2 million (down 14.09% YoY), and the FY2025 annual result was $338.4 million, down 6.77% from the prior year.
• Other Operating Expenses declined to -$13.8 million in Q1 2026 per RGEN's latest filing, from $92.6 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $131.9 million in Q4 2024 and troughed at -$13.8 million in Q1 2026.
• A 5-year average of $78.1 million and a median of $80.5 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses jumped 48.48% in 2024, then declined 29.82% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $73.6 million in 2022, then climbed by 20.74% to $88.8 million in 2023, then soared by 48.48% to $131.9 million in 2024, then slipped by 29.82% to $92.6 million in 2025, then tumbled by 114.87% to -$13.8 million in 2026.
• Business Quant data shows RGEN's Other Operating Expenses at -$13.8 million in Q1 2026, $92.6 million in Q4 2025, and $84.1 million in Q3 2025.